drugset / Trial / NCT00434447

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

NCT00434447

Phase 4 Completed 73 enrolled Novartis Pharmaceuticals
Non-randomizedSingle-groupOpen-labelPrevention

Summary

This study is designed to monitor the safety and efficacy of long-term treatment with zoledronic acid by assessing the incidence of, renal impairment, osteonecrosis of the jaw(ONJ), overall safety and skeletal related events (SREs) beyond 12 months treatment

Timeline

Start
2006-12
Primary completion
2009-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Zoledronic acid Other / unclassified

Indications